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ABSTRACT The bioactivity of galectin-1 in cell growth regulation and adhesion prompted us to answer the questions whether
ligand presence and a shift to an aprotic solvent typical for bioafﬁnity chromatography might alter the shape of the homodimeric
human lectin in solution. We used small angle neutron and synchrotron x-ray scattering studies for this purpose. Upon ligand
accommodation, the radius of gyration of human galectin-1 decreased from 19.16 0.1 A˚ in the absence of ligand to 18.26 0.1 A˚.
In the aprotic solvent dimethyl sulfoxide, which did not impair binding capacity, galectin-1 formed dimers of a dimer, yielding
tetramers with a cylindrical shape. Intriguingly, no dissociation into subunits occurred. In parallel, NMR monitoring was
performed. The spectral resolution was in accord with these data. In contrast to the properties of the human protein,
a nonhomologous agglutinin from mistletoe sharing galactose speciﬁcity was subject to a reduction in the radius of gyration from
;62 A˚ in water to 48.7 A˚ in dimethyl sulfoxide. Evidently, the solvent caused opposite responses in the two tested galactoside-
binding lectins with different folding patterns. We have hereby proven that ligand presence and an aprotic solvent signiﬁcantly
affect the shape of galectin-1 in solution.
INTRODUCTION
Lectins constitute a superfamily of ubiquitously distributed
proteins which are described and characterized in a steadily
increasing number of publications (Ru¨diger et al., 2000).
They are deﬁned as carbohydrate-binding proteins which are
distinct from immunoglobulins, do not enzymatically alter
the structure of their ligands, and do not act as sensor/
transport proteins for free mono- or disaccharides. The cur-
rent interest in the analysis of lectins and protein-carbohy-
drate interactions originates mainly from two areas. First,
due to the emergence of the concept that oligosaccharides
can serve as information-storing code units (Solı´s et al.,
2001; Gabius et al., 2002), these carbohydrate-speciﬁc bind-
ing proteins can be assigned to mediate crucial cell activities
including fertilization, cell growth and apoptosis, cell
adhesion and migration, endocytosis, and immune mediator
production/release (Gabius, 1987, 2000, 2001a; Lis and
Sharon, 1998; Sinowatz et al., 1998; Andre´ et al., 1999;
Reuter and Gabius, 1999; Rorive et al., 2001; Angata and
Brinkman-van der Linden, 2002; Dahms and Hancock,
2002; Weigel and Yik, 2002). Second, lectins have the
ability to bind glycans with distinct structures. They can thus
be employed as versatile tools to isolate and characterize
diverse glycans of medical or technological interest (Cum-
mings, 1997; Cartellier et al., 2002). In this area of appli-
cation, e.g., when working with glycolipids, it will be
necessary to use organic solvents; for example, an aprotic
solvent such as dimethyl sulfoxide (DMSO) to substitute the
natural aqueous environment for disrupting micelles formed
by glycolipids. An illustrative example for such an appli-
cation is the puriﬁcation of glycolipids by lectin afﬁnity
chromatography performed in tetrahydrofuran (Smith and
Torres, 1989). Another emerging approach using aprotic
solvents is the conformational analysis of bound carbohydrate
ligands by transferred nuclear Overhauser effect spectros-
copy exploiting the water-exchangeable hydroxyl protons as
sensors (Siebert et al., 2000). However, it is currently not
generally known how the solvent change will affect lectin
structures and consequently the ligand-binding properties.
Because water is the natural solvent for proteins (Israel-
achvili and Wennerstro¨m, 1996), most studies of biological
interaction have focused on an aqueous environment. A
notable exception is the study of nonaqueous enzymology.
Spurred by the technological interest to exploit enzyme activ-
ity in organic solvent for synthetic procedures, considerable
progress has been achieved in the analysis of response of
enzyme activities toward solvent changes (Singer, 1962;
Klibanov, 2001; Mattos and Ringe, 2001). Intriguingly,
enzymes such as lipase, lysozyme, and subtilisin retained
their activities in organic solvents (Klibanov, 2001;
Sandoval et al., 2001). Furthermore, they were found to
exhibit remarkable changes of their properties including
altered speciﬁcity, increased thermal stability, and molecular
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memory (Fitzpatrick et al., 1993; Dai and Klibanov, 1999;
Klibanov, 2001). These properties prompted their exploita-
tion in large-scale synthetic procedures, in which using an
organic solvent as reaction medium can offer advantages
such as increased solubility of hydrophobic compounds and
an improved recovery of products (Sandoval et al., 2001;
Lee and Dordick, 2002).
To initiate the detailed analysis of solvent-dependent
alterations of lectin structure, we selected an endogenous
lectin from the galectin family as a role model based on the
following reasons: 1), galectins are widely present in human
and animal tissues with relevance for mediation of the
mentioned cellular processes (Kaltner and Stierstorfer, 1998;
Andre´ et al., 1999; Gabius, 2001b; Lahm et al., 2001;
Cooper, 2002; Danguy et al., 2002; Rabinovich et al., 2002);
2), the application of endogenous lectins for analytical and
medical procedures is preferable to that of plant lectins,
because these two types of lectins differ in their ﬁne-
speciﬁcities, rendering physiological considerations based
on measurements with plant lectins problematic, and be-
cause the tissue product will be nonimmunogenic enabling
therapeutic trials (Rabinovich et al., 1999, 2002; Gabius,
2001a,b); 3), galectins from mammals, other vertebrates, and
also invertebrates share a general folding pattern, i.e., the
jellyroll motif, with pentraxins, the intracellular chaperones
calnexin/calreticulin and transporter ERGIC53/p58, neurex-
ins, and leguminous lectins (Gabius, 1997; Lis and Sharon,
1998; Shirai et al., 1999; Varela et al., 1999; Bianchet et al.,
2000; Ru¨diger and Gabius, 2001; Loris, 2002), the results
therefore harboring relevance beyond the galectin family;
4), galectin-1 has been demonstrated to bind to neu-
tral glycolipids and gangliosides with biological implication
for cell adhesion and growth control (Mahanthappa et al.,
1994; Kopitz et al., 1998, 2001), enabling puriﬁcation of
bioactive glycolipids by using galectin-1 in afﬁnity chroma-
tography as demonstrated for glycoproteins (Gabius et al.,
1991); 5), human galectin-1 has been shown to trigger
clinically relevant processes such as tumor invasion into
parenchyma in glioblastoma, T-cell apoptosis in the Se´zary
syndrome and immunological disorders such as autoimmune
diseases, and induction of nonclassical apoptosis in neuro-
blastoma with relevance for tumor regression (Kopitz et al.,
2001; Rorive et al., 2001; Camby et al., 2002; Rabinovich
et al., 2002; Rappl et al., 2002); 6), the quaternary structure
of this galectin is indispensable for ligand cross-linking
triggering signaling (Villalobo and Gabius, 1998; Brewer,
2002); and 7), galectin-1 has been shown by ligand assays
and NMR spectroscopy to retain carbohydrate-speciﬁc
binding in DMSO (Siebert et al., 2000). As mentioned
above, this property affords access to conformational pa-
rameters of the otherwise elusive hydroxyl protons to im-
prove the description of the ligand’s bound-state topology.
Such information is essential for further reﬁnements in drug
design by rational afﬁnity enhancements (Gabius, 1998;
Ru¨diger et al., 2000; Andre´ et al., 2001). Based on this
reasoning we decided to assay the properties of human
galectin-1 as a model system in DMSO (as aprotic solvent)
relative to water.
To gain insight into the response of protein structure to
exposure to an organic solvent, investigation of the protein’s
conformation in water is the ﬁrst step. Monitoring protein
structure in the aprotic solvent then allows direct comparison
of these structure data with those obtained in aqueous en-
vironment, as previously performed for the enzyme sub-
tilisin Carlsberg (Griebenow and Klibanov, 1997). For such
a comparison to be completed, the availability of the atomic
structure from x-ray crystallography and/or from NMR
spectroscopy is very helpful. Fitzpatrick et al. (1993, 1994)
elucidated this enzyme’s crystal structure in acetonitrile and
in water. A major conclusion of their work was that its
structure in the organic solvent was signiﬁcantly rigidiﬁed
(i.e., a reduction in mobility) compared to that when being
dissolved in water. This change was reﬂected on the level of
the overall average B factor decreasing from 13.8 A˚2 to 10.4
A˚2. This parameter is a measure for the relative mobility of
atoms. However, because the crystal packing force might
inﬂuence this aspect of protein behavior, it is necessary to
further analyze proteins free in solution (in aqueous and
nonaqueous media). As also brieﬂy demonstrated in our
study, the scope of analysis of proteins with molecular
masses beyond 10–12 kDa by NMR spectroscopy will often
be severely restricted. At this stage, other approaches to
measure structural parameters of proteins come into play.
Solution scattering provides information on the overall
size and shape of proteins in solution under conditions which
are close (if not identical) to being physiological (Zaccai and
Jacrot, 1983; Vachette and Svergun, 2000). Recent studies
have even proven that low-resolution structures of biological
macromolecules including proteins can be successfully
calculated from solution scattering curves using ab initio
approaches (Chaco´n et al., 1998; Svergun, 1999; Byron and
Gilbert, 2000; Svergun et al., 2001). Also, solution scattering
has proven valuable to determine dynamic conformation
transition of proteins at various solvent conditions (Re´at
et al., 2000; Tehei et al., 2001; Paciaroni et al., 2002). In the
present study, small angle neutron scattering (SANS) and
small angle x-ray scattering (SAXS) experiments were
performed to study the conformation of human galectin-1
in water and in the organic solvent. With the available data
set of the crystal structure of the closely related bovine
galectin-1 (Bourne et al., 1994; Liao et al., 1994), we
analyzed the solution scattering data of human galectin-1 in
water and DMSO in detail. By employing the ab initio-
method referred to as dummy atom model (DAM), we also
obtained information, if and to what extent the shape and
quaternary structure of galectin-1 change in DMSO. To
address the issue whether the behavior observed for human
galectin-1 will only be encountered for a protein with the
jellyroll-like motif, we further tested another galactose-
binding lectin which retains ligand-binding capacity in
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DMSO (Siebert et al., 2000). It is a toxic protein from
mistletoe, referred to as Viscum album agglutinin (VAA). Its
folding pattern, closely related to that of ricin, is a double
trefoil structure in crystals (Sweeney et al., 1998).
MATERIALS AND METHODS
Materials
N-Acetyllactosamine and [D6]DMSO (deuteration grade [99.9%) were
purchased from Sigma Chemical (Steinheim, Germany). D2O (deuteration
grade[99.8%) was obtained from Merck (Darmstadt, Germany). A high-
purity water system was used to produce H2O. All other reagents were of
analytical grade.
Puriﬁcation of galectin-1 and VAA
Human galectin-1 was puriﬁed from placenta using afﬁnity chromatography
on lactosylated Sepharose 4B as the crucial step, and standard electrophoresis
and gel ﬁltration analyses as well as hemaglutination assays were used to as-
certain purity (Gabius et al., 1985, 1987; Gabius, 1990). To protect galectin-1
against oxidative inactivation, it was treated with a cysteine-modifying
reagent, iodoacetamide, during elution from the afﬁnity resin (Powell and
Whitney, 1984; Whitney et al., 1986). Further quality control included
spectroscopic analysis (UV spectra, circular dichroism) using the data from
Sharma et al. (1990) as reference values. The galectin-1 fractions were
extensively dialyzed against water and lyophilized. The puriﬁcation of VAA
started from aqueous extracts of dried mistletoe leaves and also used afﬁnity
chromatography on lactosylated Sepharose as the crucial step as previously
described (Gabius, 1990). Analysis by gel ﬁltration, gel electrophoresis,
ligand binding, and cell growth assays ascertained the maintenance of the
disulﬁde bridge between the two subunits of the AB-toxin and its biological
activity after lyophilization (Andre´ et al., 2001; Gabius et al., 2001).
Preparation of samples
The buffers were ﬁltrated through 0.2 mm Millipore membranes to remove
any particle contaminations. To prepare the aqueous solution of the protein
under study, lyophilized galectin-1 powder was dissolved in 20 mM
phosphate buffer (pH 7.2, prepared with H2O for SAXS and dynamic light
scattering experiments; pD 7.2, prepared with D2O for SANS experiments).
The required pD (D2O) and pH (H2O) values of the buffers were obtained by
mixing standard solutions after calculation using the pKa-values of the
phosphate salts. The pH value of the buffer using H2O was conﬁrmed by
a glass electrode measurement (deviation between measurement and
theoretical calculation was 0.02). The protein solutions were centrifuged
to remove any insoluble material. Because galectin-1 is highly soluble in
phosphate buffer, its concentration in the buffer was calculated by weight
balance. To ensure that there was no water in organic solution of galectin-1,
neat [D6]DMSO was added to lyophilized galectin-1 powder. After gently
shaking, the remaining fraction of protein not dissolved in DMSO was
removed by centrifugation at 5000 rpm for 10 min, and the supernatants
were centrifuged a second time under the same condition to ensure removal
of residual undissolved material. The galectin-1 concentration in DMSOwas
measured by the Bradford method using pure galectin-1 in phosphate buffer
as standard (Bradford, 1976). To yield the same concentration in DMSO as
that in water, the galectin-1 amount required was doubled due to solubility
problems. Solutions containing VAA were prepared using essentially the
same procedure. Interestingly, lyophilized powder of VAA is very soluble in
neat DMSO and a concentration of 9.6 mg/ml can readily be reached,
whereas its solubility after lyophilization was rather restricted in phosphate
buffer, nearly half of VAA remaining insoluble. To keep all parameters
constant except for the choice of the solvent, lyophilized samples were
routinely used as starting material.
NMR experiments
500MHz 1H-NMR spectra were recorded with an AMX 500 spectrometer at
300 K using lectin solutions in either D2O or [D6]DMSO. As starting
material, 3 mg of lectin was dissolved in 0.5 ml solvent. To obtain spectra
free of artifacts for direct comparison, parameter settings (td ¼ 32 k; sw ¼
16 ppm; p1 ¼ 308; d1 ¼ 0.1 s; and ns ¼ 80) were kept constant.
SANS experiments
The SANS experiments were performed on the instrument SANS-1 at the
Geesthacht Neutron Facility GeNF, Geesthacht, Germany (Stuhrmann et al.,
1995). Four sample-to-detector distances (from 0.7 to 7 m) were employed
to cover the range of the modules of the scattering vectors q (q¼ 4p sin u/l,
where 2u is the scattering angle and l is the wavelength) from 0.01 to
0.25 A˚1. In all experiments, the neutron wavelength lwas 8.5 A˚ (measured
by routine time-of-ﬂight experiments) with a wavelength resolution of 10%
(full width at half-maximum value). The calibration of q was performed by
scattering measurements of silver behenate. The samples were kept in quartz
cells (Hellma, Mu¨llheim, Germany) with a path length of 1 mm, which were
placed in a thermostatic sample holder to maintain isothermal conditions.
The two-dimensional isotropic scattering patterns were azimuthally
averaged, converted to an absolute scale, and corrected for detector
efﬁciency by using the incoherent scattering pattern of pure water (Wignall
and Bates, 1987). The background from the solvent and sample cell was
subtracted from the raw patterns by conventional procedures (Cotton, 1991).
SAXS experiments
Following standard experimental procedures (Koch and Bordas, 1983;
Boulin et al., 1988), the SAXS experiment was performed on the instrument
X33 NCS at the European Molecular Biology Laboratory outstation in
Hamburg, Germany. The measurements were carried out with a position-
sensitive gas detector at a wavelength of 1.5 A˚. The modules of the
scattering vector were calibrated by using collagen (periodicity of 65 nm)
and tripalmitin (periodicity of 4.06 nm) as standards. The data were
normalized to the incident beam and corrected for detector response.
Scattering by the buffer background, which was detected before and after the
sample measurements, was subtracted from the data of the sample. All
procedures involving statistical error estimation were performed using the
program SAPOKO (D.I. Svergun and M.H.J. Koch, unpublished results).
Diffusion coefﬁcients
The experimental diffusion coefﬁcient of the protein in phosphate buffer was
measured by dynamic light scattering using the DYNAPro99 system
(Protein Solution, Lakewood, NJ). The laser wavelength was 8312 A˚ and the
scattering angle was 908. The program Hydro (Garcia de la Torre et al.,
2000) was used to estimate the theoretical diffusion coefﬁcient from the
protein crystal structure. The method was based on bead-modeling strat-
egies. Starting from the atomic structure of a protein, the program ﬁrst con-
structs a ﬁlling model in which the protein is represented by a particle ﬁlled
with beads arranged in the most closely packed hexagonal lattice. In the next
step, all internal beads are removed and the program ﬁnally obtains a rough
shell model which is an adequate description of the hydrodynamic properties
(e.g., diffusion coefﬁcient) of an arbitrarily shaped particle.
IFT analysis of the scattering data
To obtain the radii of gyration of the particles and their pair distance
distribution function p(r), the indirect Fourier transformation (IFT) method
was employed to process scattering data. The IFT method does not require
a pre-assumption regarding the shape of the particles. In the IFT method
(Glatter, 1977), the radius of gyration of particles is given as
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R
2
g ¼
Ð Dmax
0
pðrÞr2 dr
2
Ð Dmax
0
pðrÞ dr ; (1)
where Dmax is the upper limit for the maximum particle dimension which
satisﬁes p(r) ¼ 0 at r [ Dmax, and p(r) is the pair distance distribution
function of a particle. The p(r) function is approximated by a linear
combination of a ﬁnite number of cubic B-spline functions ui(r),
pðrÞ ¼ +
N
i¼1
ciuiðrÞ; (2)
where the expansion coefﬁcients ci are ﬁtting parameters determined from
the scattering data. The values of Dmax were carefully chosen to ensure
accurate ﬁtting of the experimental data and smooth p(r) functions. In the
present work, IFT analyses were performed by the program GNOM us-
ing perceptual criteria (Svergun, 1992) and/or by the Fortran program
GLATTER.FOR provided by Pedersen (Pedersen et al., 1990; Pedersen,
1997), in which background such as incoherent scattering by protons of the
sample can be taken into account. These two procedures of analysis gave
identical results.
Scattering data evaluation from
atomic coordinates
The scattering data were further evaluated from atomic coordinates using the
program CRYSON for SANS data (Svergun et al., 1998) and the program
CRYSOL for SAXS data (Svergun et al., 1995). In both programs, the
scattering from the protein is calculated as
IðqÞ ¼ jAðqÞ  rsEðqÞ1 ðrb  rsÞBðqÞj2
 
V
; (3)
where A(q) is the atomic scattering amplitude from the protein in vacuum,
E(q) and B(q) refer to the scattering from the excluded volume and the
solvent shell, respectively, rs is the density of the bulk solvent, and rb is the
density of the solvent layer. In the aqueous system (D2O or H2O), a default
value of 1.13 rs is employed for rb in the calculation (Svergun et al., 1998).
For the protein in DMSO, we assumed that the density of the solvent layer
rb is identical to the density of the bulk solvent rs.
Model ﬁtting
Simple geometrical arrangements such as an ellipsoid or a cylinder are often
used to gauge the shape of particles such as micelles and proteins (Pedersen,
1997; He et al., 2000, 2002). The shape parameters for these simple
topologies can be determined by ﬁtting the scattering data. The detailed
mathematical descriptions of the cylindrical and ellipsoidal models are given
in the literature (Feigin and Svergun, 1987; Pedersen, 1997; He et al., 2002).
To analyze the mixture properties of the protein in solution (e.g., mixture
of monomer and oligomers), the programs OLIGOMER and MIXTURE
were employed. These programs can be obtained from the web site of the
European Molecular Biology Laboratory outstation Hamburg (http://
www.embl-hamburg.de/ExternalInfo/Research/Sax/program.html).
Calculation of galectin-1 structure in DMSO
The shape of the galectin-1 in DMSO was calculated from the neutron
scattering data using the program DAMIN (i.e., ab initio shape de-
termination by simulated annealing using a single phase dummy atom model
(DAM), as described by Svergun, 1999). Looseness and interconnectivity
criteria were employed in DAM to ensure that the obtained model is
physically meaningful. In the calculation procedure, a sphere with a diameter
Dmax is ﬁlled by a regular grid of points corresponding to a dense hexagonal
packing of small spheres (dummy atoms) of the radius r0 (r0  Dmax). The
structure of the DAM is deﬁned by a conﬁguration vector X assigning an
index to each atom (‘‘0’’ corresponds to solvent and ‘‘1’’ to the solute
particle). Scattering intensity from DAMwas calculated and compared to the
experimental scattering curve. This ﬁtting process was performed using
simulated annealing to achieve the global minimization of f(X):
f ðXÞ ¼ x21a3PðXÞ; (4)
where a[ 0 is the weight of the looseness penalty, P(X) is the function de-
scribing the average looseness, and x is the discrepancy which is deﬁned as
x ¼ 1
N  1+
N
j¼1
IðqjÞ  IexpðqjÞ
sðqjÞ
 2
; (5)
where N is the number of experimental points, I(q) is the calculated intensity,
Iexp(q) is the experimental intensity, and s is the standard deviation of the
experimental intensity. Detailed description of DAM can be found in the
literature (Svergun, 1999).
It should be noted that the experimental scattering intensity was
subtracted by a constant before being ﬁtted by the DAMIN program. The
data after subtraction are referred to as shape-scattering data. This treatment
ensured that the data did not contain internal structure information of the
protein. The constant was determined by the slope in the curve of I 3 q4
against q4 at high angle. Thus, the intensity after subtraction decays as q4 at
high q-value, following Porod’s law for homogeneous particles (Porod,
1982; Svergun, 1999).
RESULTS AND DISCUSSION
Monitoring the scattering proﬁle of galectin-1 in
aqueous solution and comparison of structural
aspects in solution and crystal
To study structural aspects of human galectin-1 in solution,
SANS and SAXS analyses were carried out, starting with
monitoring in aqueous solution. Except for an early report on
human galectin-1 after storage (Hirabayashi et al., 1987), the
majority of respective contributions on this topic agreed on
the result obtained by gel ﬁltration and hemaglutination that
this prototype galectin is a homodimer in buffered solution
(Gabius et al., 1985; Allen et al., 1987; Nambiar et al., 1987;
Giudicelli et al., 1997). It is also known that bovine galectin-1
exists as a dimer in the crystal phase (Bourne et al., 1994;
Liao et al., 1994). b-Sheet hydrogen bonding across the
monomer surface in the interface and formation of a hy-
drophobic core stabilized the contact (Liao et al., 1994;
Varela et al., 1999). Because the amino-acid sequence of
human galectin-1 (Hirabayashi and Kasai, 1988; Abbott and
Feizi, 1989; Couraud et al., 1989; Hirabayashi et al., 1989;
Bladier et al., 1991) shows a high identity (86%, pairwise
alignments) to that of bovine galectin-1 (Abbott et al., 1989),
the available crystal structure of bovine galectin-1 (PDB
entry 1SLT) was conﬁdently employed to evaluate the
scattering data using the program CRYSOL. Also, homology
modeling with calculation of surface accessibilities for
selected amino acid residues (i.e., His, Tyr, and Trp) and
the experimental determination of these parameters by the
laser photo-CIDNP (chemically induced dynamic nuclear
polarization) technique for human and bovine galectin-1
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underscored the validity of this approach (Siebert et al.,
1997). In Fig. 1 A, the experimental SAXS spectra and the
theoretical curve predicted by CRYSOL on the basis of
crystallographic data illustrated in Fig. 1 B are compared. In
the theoretical prediction, default parameters (the theoret-
ical excluded volume and a hydration layer density of 1.1
g/ml) were employed. At low q-values, experimental and
theoretical data sets are evidently in good agreement. At high
q-values, although discrepancies between the experimental
points and the theoretical curve were observed, these
differences were within the limit of experimental errors
(ﬁtting results with x ¼ 0.559). This result lends credence to
the conclusion that human galectin-1 has a similar confor-
mation in crystal and in aqueous solution, corroborating the
mentioned experimental evidence. In addition, we performed
monitoring of the scattering spectra in SANS and deter-
mination of the diffusion coefﬁcient. Unequivocally, the
results from these experimental approaches delineated the
homodimeric nature of human galectin-1 in buffered
aqueous solution. The comparison between the experimental
results and the theoretical value calculated from the atomic
coordinates of the crystal structure are summarized in
Table 1. The experimental values from three different
measurements obviously accord remarkably well with those
predicted from atomic coordinates. Crystal packing will
thus not affect the structural parameters, as determined in
solution by the applied methods. One particular aspect of
Table 1 deserves further comment.
As shown in Table 1, the radius of gyration of galectin-1
measured by SAXS (20.8 A˚) is larger than that assessed by
SANS (19.1 A˚). Recently, this general phenomenon that
SAXS and SANS data can give different radii of gyration for
an identical protein was explained by Svergun et al. (1998).
At the protein-solvent interface, there is a tightly bound
hydration layer whose density is higher than that of the bulk
solvent. Due to the different scattering length densities of
molecules for SANS and SAXS, the comparatively very
dense hydration layer can contribute markedly to the radius
of gyration measured from SAXS in a positive way, whereas
it affects that from SANS negatively (Svergun et al., 1998).
This phenomenon results in a higher value for the radius of
gyration of proteins from SAXS data than that from SANS
data. Having veriﬁed the validity of these experimental
approaches for this protein under study, we next addressed
the issue whether binding of the ligand can affect structural
parameters of galectin-1 in solution.
Another aspect deserves special attention at this stage. To
keep experimental conditions similar (if not identical) and
also to facilitate solvent exchange, we worked with
lyophilized proteins. Our results revealed that the structure
of the rehydrated protein in aqueous medium is indistin-
guishable from the crystal structure excluding a major
FIGURE 1 (A) Comparison of the experimental SAXS
spectra of human galectin-1 with the theoretical prediction
(solid curve) based on the atomic structure. Experimental
condition was 9 mg/ml galectin-1 in 20 mM phosphate
buffer (H2O), pH 7.2, measured at room temperature. In the
theoretical calculation by the program CRYSOL, the
density of the hydration layer at the protein-solvent
interface was assumed to be 10% higher than that of the
bulk solution (Svergun et al., 1998). (B) The crystal
structure of bovine galectin-1 (PDB entry 1SLT) was
employed in the prediction. The structure on the right was
rotated counterclockwise by 908 around the x-axis. The
axes in the bottom were drawn in the scale rod of 1 nm.
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structure change or denaturation, as discussed for other
protein types (Griebenow and Klibanov, 1995). These in-
sights into global aspects of galectin-1 structure are in ag-
reement with lessons drawn from the activity assays after
rehydration (Siebert et al., 2000). Regarding the comparison
between structural aspects in the crystal and in solution, we
next addressed the question as to whether and to what extent
binding of the ligand to the carbohydrate recognition domain
affects this receptor’s overall shape. It is in fact an open
question whether ligand diffusion into a crystal is capable to
trigger those conformational alterations in the highly packed
arrangement, which might occur for individual protein
molecules free in solution.
Effect of ligand presence on the conformation
of galectin-1
N-Acetyllactosamine is a proven high-afﬁnity ligand for
galectin-1. In isothermal titration calorimetrical experiments
at 300 K, DG of binding by bovine galectin-1 was de-
termined to be 5.5 kcal/mol (Ahmad et al., 2002). Oli-
gomers of this ligand, i.e., poly-N-acetyllactosamine, are
present in glycan chains of natural galectin ligands such as
laminin and lysosome-associated membrane proteins (Andre´
et al., 1999). Topological consequences of the binding pro-
cess have been delineated in the case of the ligand. The
disaccharide can exhibit three different low-energy con-
formations deﬁned by distinct f, c-combinations of the
dihedral angles of the glycosidic bond, and the combination
of molecular modeling with NMR spectroscopic measure-
ments demonstrated that galectin-1 and its homologs
selected the syn conformation of the ligand from the
ensemble of the three conformers present in solution (Siebert
et al., 1996; Gabius, 1998; Asensio et al., 1999; Alonso-
Plaza et al., 2001). Our experimental design will enable us to
monitor structural properties of the receptor upon ligand
binding in solution. The ligand effect on galectin-1 structure
was studied by SANS. In Fig. 2 A, the scattering spectra of
galectin-1 in the presence and the absence of 10 mM
N-acetyllactosamine are compared. At low angle, the scat-
tering intensities in the presence of ligand were lower than
those in the absence of the ligand. On the contrary, the
presence of ligand resulted in an increase of the intensities at
high angle. These scattering data were further analyzed by
the IFT methods to obtain their p(r) function and the radius
of gyration. The radius of gyration of human galectin-1 in the
presence of the ligand was 18.26 0.1 A˚ whereas the value in
the absence of the ligand was 19.1 6 0.1 A˚. Because of
the small inherent error (0.1 A˚) in our determination of the ra-
dius of gyration, this measured difference is generally consid-
ered to be a signiﬁcant indication for a structure change of
a protein (Krueger et al., 1998). This result suggests that
galectin-1 has a compressed structure after accommodating
the ligand. Further evidence for this conclusion is given by
the p(r) function. As shown in Fig. 2 B, the peak of the
p(r) function slightly shifted toward a smaller r-value in the
presence of the ligand. This impact of the ligand on galectin-1
structure prompted further analysis of a parameter known
to affect ligand afﬁnity with respect to galectin structure. In
this context, it should be noted that the spectra of scattering
at low concentrations (2.1 and 3.0 mg/ml) of the protein
were also measured at low angle (0.01–0.1 A˚1). The data
(not shown) normalized with concentration (intensities
divided by the concentration) were in good agreement with
the data at the high concentration (7.6 mg/ml) discussed
above. This quality control afﬁrms that the solutions were
within the dilute region and the interparticle interactions can
reliably be ignored, satisfying the conditions for successful
application of the IFT method.
Temperature effect in aqueous solution
Alteration of the temperature in a series of measurements in
isothermal titration calorimetry has revealed the inﬂuence of
this parameter on the afﬁnity of galectin-1 with its ligands.
At 287 K the DG-value for N-acetyllactosamine increased to
5.7 kcal/mol (Ahmad et al., 2002). The binding constant of
bovine galectin-1 with N-acetyllactosamine also followed
a van’t Hoff-typical pattern, ranging from 6.5 3 104 M1 at
281 K to 1.0 3 104 M1 at 298 K (Schwarz et al., 1998;
TABLE 1 Comparison of experimental results and theoretically calculated data of galectin-1 in aqueous solution
Experiments Calculation from crystal structure
Experimental conditions* Measured valuey Calculated valuez Program§
SAXS c ¼ 9 mg/ml, in H2O, room
temperature
Rg ¼ 20.8 6 0.3 A˚ Rg ¼ 20.6 A˚ (20.9 A˚) CRYSOL
SANS c ¼ 7.6 mg/ml, in D2O,
T ¼ 298 K
Rg ¼ 19.1 6 0.1 A˚ Rg ¼ 18.6 A˚ (18.9 A˚) CRYSON
DLS c ¼ 1 mg/ml, in H2O,
T ¼ 293 K
D ¼ 7.9 3 107 cm2/s D ¼ 8.2 3 107 cm2/s Hydro
*All experiments were performed in 20 mM phosphate buffer (pH 7.2 for H2O and pD 7.2 for D2O).
yRg, radius of gyration; D, diffusion coefﬁcient.
zCalculated from the atomic coordinates of bovine galectin-1 available in the Protein Data Bank (PDB entry 1SLT), the values in brackets were calculated
based on the atomic coordinates of galectin-1 from amphibian species (Vasta et al., 1997; Bianchet et al., 2000) using PDB entry 1GAN.
§Default parameter values in the programs were employed, and there was no ﬁtting of the experimental data.
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Ahmad et al., 2002). Further examples for the temperature
dependence of binding of a panel of ligands by bovine,
hamster, and sheep galectin-1 have also been reported
(Ramkumar et al., 1995; Gupta et al., 1996; Schwarz et al.,
1998). To study any temperature effect on lectin conforma-
tion, especially its quaternary structure, the SANS spectra of
galectin-1 in phosphate buffer at a concentration of 7.6 mg/
ml in the presence of 10 mM N-acetyllactosamine were
measured at 288 K and 298 K, respectively. As shown in Fig.
3 A, the scattering spectra at the two temperatures are nearly
identical. Also, their pair distance functions disclosed no
evidence for a notable difference (Fig. 3 B). These data
indicate that no signiﬁcant change of the ligand-induced
effect occurred within the tested temperature range (288 K–
298 K). Explicitly, no oligomerization or dimer dissociation
appears to be likely, attributing changes in the binding con-
stant to the immediate microenvironment of the binding
sites. Having thus characterized the aggregation status of
galectin-1 in solution, we proceeded toward our further aim
to analyze its shape in the aprotic solvent.
Monitoring the scattering proﬁle in DMSO
As given in detail in the Methods section, lyophilized
galectin-1 was dissolved in pure DMSO at a concentration of
8.1 mg/ml for routine measurements. The scattering behavior
of galectin-1 in phosphate buffer and DMSO is compared
in Fig. 4. Using the IFT method, the radii of gyration of
galectin-1 in phosphate buffer and DMSO were calculated to
be 19.1 and 32.6 A˚, respectively. Obviously, oligomerization
of human galectin-1 occurred in DMSO. But its extent was
limited and deﬁned, not leading to large and heterogeneous
aggregate complexes. This event was also reﬂected by the
fair degree of signal resolution in one-dimensional 1H-NMR
spectra of the lectin in [D6]DMSO relative to that in D2O
(data not shown).
The comparison of the p(r) function for this protein in
the two solvents disclosed a further structural alteration.
Notably, the shape of galectin-1 in DMSO became obviously
elongated. As shown in Fig. 4 B, the two p(r) functions for
FIGURE 3 Comparison of SANS behavior of galectin-1 at 288 K and at
298 K. Experimental condition was 20 mM phosphate buffer (D2O), pD 7.2,
and galectin-1, c ¼ 7.6 mg/ml, in the presence of 10 mM N-acetyllactos-
amine.
FIGURE 2 SANS behavior of human galectin-1 in the absence (Curve 1)
and presence (Curve 2) of 10 mM N-acetyllactosamine. (A) SANS spectra
of galectin-1 in 20 mM phosphate buffer (D2O), pD 7.2, galectin-1
concentration, c ¼ 7.6 mg/ml, and Temperature, T ¼ 298 K; (B) p(r)
function of the scattering data. The p(r) function was normalized to set the
integrated area value of the p(r) function to ‘‘1’’. In the absence of ligand
(Curve 1), the radius of gyration, Rg, was 19.1 6 0.1 A˚; in the presence of
ligand (Curve 2), the Rg was 18.2 6 0.1 A˚.
Solvent Dependence of Lectin Structure 517
Biophysical Journal 85(1) 511–524
galectin-1 in phosphate-buffered aqueous solution and in
DMSO have their maximum value around the r-value of
20 A˚. However, the maximum dimension Dmax in DMSO
(115 A˚) is considerably larger than that in phosphate buffer
(65 A˚). Because galectin-1 forms a dimer in phosphate buf-
fer, the p(r) function is in line with establishment of a dimer
of dimers (i.e., tetramer of monomers) for galectin-1 in solu-
tion of DMSO. To obtain a more detailed insight into the
shape of galectin-1 in DMSO, further data analysis was per-
formed by model ﬁtting.
Shape of galectin-1 in DMSO
The IFT method gains access to certain parameters of the
structure of proteins such as their radius of gyration and p(r)
function. As discussed in the preceding paragraphs, the p(r)
function of galectin-1 in DMSO satisﬁed characteristics of an
elongated particle. This result provided the starting point for
extending the modeling of structural aspects. To get these
calculations started, we chose a simple geometry, i.e., cy-
linder, to ﬁt the experimental scattering data. Fitting the ex-
perimental curve with the cylindrical model resulted in
a cylinder with a radius of 18.4 A˚ and a length of 115 A˚. As
illustrated by Curve 4 in Fig. 5, the cylindrical model can
approximately describe the scattering data at low angle
values. When moving to larger angles, deviations became
apparent. To check whether this emerging discrepancy is
due to coexistence of monomers and oligomers, the pro-
gram MIXTURE was employed. As the exclusive calcula-
tion showed, there was little improvement of the ﬁtting by
assuming that there were mixtures of polydisperse compo-
nents (data not shown). Also, ﬁtting the data by the program
OLIGOMER provided evidence that the solution apparently
contained no signiﬁcant amount of monomers, dimers, or
other oligomers (for instance, octamers) besides tetramers.
The low-resolution shape of galectin-1 in DMSO was
determined by the ab initio program DAMIN. As expected,
the scattering curve computed by DAMIN program gave best
ﬁtting (Curve 5 in Fig. 5, with x ¼ 1.069) for the shape-
scattering data. Starting from different random approxima-
tions, several independent calculation procedures were
performed which arrived at similar protein shapes. In Fig.
6 A, a typical representation of the calculated shape of
galectin-1 in DMSO is presented. It clearly shows that
human galectin-1 exists as a tetramer in DMSO. Calculation
with the DAMIN program gave a total excluded DAM
volume of 66.7 nm3. Note in this context that the volume of
the dimer in D2O is 35.7 nm
3, estimated from the crystal
structure (PDB entry 1SLT) by the program CRYSON. This
difference suggests that association of two dimers appears to
be a plausible approximation for the protein shape in DMSO,
FIGURE 4 Comparison of SANS behavior of human galectin-1 in
phosphate buffer and in pure DMSO. (A) SANS spectra of galectin-1 in
the two solvents; (B) p(r) function of the scattering data. Curve 1, 7.6 mg/ml
galectin-1 in 20 mM phosphate buffer, pD 7.2; T ¼ 298 K. Curve 2, 8.1
mg/ml galectin-1 in pure DMSO; T ¼ 298 K. The Rg in phosphate buffer
and DMSO were 19.1 and 32.6 A˚, respectively.
FIGURE 5 Theoretical ﬁtting of the experimental spectra of human
galectin-1 in DMSO. Experimental conditions: 8.1 mg/ml galectin-1 in pure
DMSO; T ¼ 298 K. Curve 1, original scattering data affording information
on shape and internal structure; Curve 2, shape-scattering data (original data
after subtraction of a constant of 0.0066; see Material and Methods for
details); Curve 3, a simple tetramer model by association of two dimers
using dimer atomic coordinates from the crystal structure (PDB entry 1SLT);
Curve 4, a cylinder model with a radius of 18.4 A˚ and a length of 115 A˚; and
Curve 5, calculated by ab initio-method, using the program DAMIN.
518 He et al.
Biophysical Journal 85(1) 511–524
actual deﬁnition of the interface contacts in DMSO re-
maining to be elucidated by crystallography.
To test our deduction computationally, a simple tetramer
(Fig. 6 B) was constructed by connecting two dimers to form
a cylindrical shape using the crystal structure of bovine
galectin-1 (PDB entry 1SLT) as information on basic aspects
of conformation in aqueous solution. The constructed simple
tetramer was used by the program CRYSON to predict
a corresponding scattering curve theoretically. As shown
in Fig. 5, the scattering curve predicted by this simple
tetrameter (Curve 3 in Fig. 5, with x ¼ 3.268) is similar to
the theoretical curve calculated by DAMIN program (curve 5
in Fig. 5). However, in the range of high-angle values, DAM
gave an improved extent of ﬁtting of the shape-scattering
data. As expected, the protein shape (Fig. 6 A) resulting from
the application of the DAMIN program is apparently the best
model for the shape of human galectin-1 in DMSO under
the tested experimental conditions. To delineate whether the
described behavior will also emerge at a concentration
different from the routinely used one, we accordingly
extended the analysis of human galectin-1 structure in
DMSO.
Effect of galectin-1 concentration on its
aggregation in DMSO
To obtain scattering data with sufﬁcient statistical validity
for calculating the shape of galectin-1 in DMSO, a protein
concentration of 8.1 mg/ml was routinely employed in
scattering experiments. It is known that oligomer formation
of proteins in aqueous solution can depend on the protein
concentration, rendering it reasonable to assume an effect of
this parameter on oligomerization of galectin-1 in DMSO.
Hence, we also measured SANS spectra of galectin-1 at
concentrations lower than 8.1 mg/ml in DMSO. In Table 2,
the radii of gyration at three different galectin-1 concen-
trations are comparatively listed. Despite the conspicuous
experimental error at the concentration of 1.8 mg/ml, the
respective value at this experimental condition is close to that
at 8.1 mg/ml. Considering that the statistical error increases
when lowering the protein concentration, we did not per-
form further measurements at even lower concentrations.
Regarding the issue of quaternary structure, the presented
results revealed that the tetramer is the preferred quaternary
structure of galectin-1 in DMSO in the tested concentration
range. To examine whether this property will also arise for
another galactoside-binding lectin, thereby deﬁning a com-
mon feature for lectins with this speciﬁcity, we measured the
respective properties of the mistletoe lectin that, similar to
galectin-1, maintains ligand binding in DMSO (Siebert et al.,
2000).
TABLE 2 Radius of gyration of galectin-1 in DMSO at
different protein concentrations
Concentration
(mg/ml)
Radius of gyration
Rg (A˚)
Maximum particle dimension
Dmax (A˚)
1.8 34.8 6 1.5 110
5.4 33.5 6 0.7 110
8.1 32.6 6 0.4 115
FIGURE 6 Visualization of the shape of human galectin-1 in DMSO. (A)
The low-resolution structure in DMSO was obtained from shape-scattering
data by the ab initio-method using the program DAMIN (curve 5 in Fig. 5).
The model bead (illustrated by a unit sphere) has a radius of r0 ¼ 3.5 A˚, and
this arrangement was visualized using the program RASMOL. The structure
on the right was rotated counterclockwise by 908 around the y-axis. (B)
Shape of the simply constructed tetramer by connecting two dimers to form
a cylindrical shape using the crystal structure of bovine galectin-1 (PDB
entry 1SLT). The x- and y-axes are drawn in the scale rod of 1 nm.
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Scattering data of VAA in water and DMSO
In detail, we carried a comparative analysis of VAA in the
two solvents under the same experimental conditions as used
for galectin-1. The resulting scattering spectra of VAA in
phosphate-buffered water and DMSO are illustrated in Fig.
7. At the small angle range, the scattering density in water
increased quickly as the scattering vector q decreased (Fig.
7 A). This behavior indicates that there were indeed large
protein aggregates in water. In contrast, the scattering curve
in DMSO did not show this type of trend, and the scattering
density reached a plateau at small angles. The given data
were further analyzed by the IFT method yielding the plots
presented in Fig. 7 B. The scattering data in water resulted in
a poor p(r) function, whereas a smooth p(r) function was
obtained from the scattering data in DMSO. By using Dmax
¼ 180 A˚, the radius of gyration in DMSO was calculated to
be 48.7 A˚. In water, the radius of gyration was calculated to
be 62 A˚ by using Dmax ¼ 200 A˚. It should be noted that the
radius of gyration in water was not a precise value because of
the poor ﬁtting of the data. At any rate, the data intimate that
a substantial extent of aggregation of VAA occurred in
water. This result can readily be reconciled with the
solubility properties and the improved level of signal
resolution in NMR spectra for VAA in the aprotic solvent
relative to that using D2O as solvent (data not shown).
Moreover, gel ﬁltration of the lectin and its carbohydrate-
binding B subunit in phosphate buffer indicated tetramer
formation for the hololectin at 50 mg/ml and interactions
between the lectin subunits leading to dimerization (Swee-
ney et al., 1998). Compared to ricin, these authors noted an
enhanced tendency of the mistletoe’s AB-toxin for aggrega-
tion. Compared to galectin-1, the differences in the response
to solvent exchange are obvious. They preclude general
predictions for the quaternary structure of a lectin in the
aprotic solvent, when classifying lectins solely based on their
carbohydrate speciﬁcity, a common classiﬁcation scheme
(Wu et al., 2001).
Correlation of scattering data for galectin-1 with
its behavior during thermal denaturation and
biological implications
Physicochemical stress can be imposed on a protein by
various factors, in our case by the solvent exchange. Dif-
ferential scanning calorimetry is another means to study
respective responses of the protein structure, in that case to
a temperature increase. In this context, it is interesting to note
that sheep and bovine galectin-1 had shown a distinct
behavior upon further temperature increases reaching the
threshold to denature the protein. Determined by differential
scanning calorimetry, sheep galectin-1 yielded transition
peaks at Tm values of 333.8 K and 340.0 K, respectively,
pointing to presence of tetramers (dimer of dimers) and
octamers (tetramer of dimers) (Surolia et al., 1997), whereas
data for bovine galectin-1 are indicative of formation of
a tetramer at the denaturation temperature (Schwarz et al.,
1998). Notably, galectin-1 maintained the association even
in the thermally unfolded state, a behavior setting it apart
from leguminous lectins which share the global jellyroll-like
folding pattern (Loris, 2002). Thus, the two physicochemical
stress factors, i.e., solvent exchange and thermal denatur-
ation, appeared to elicit identical responses, warranting
further comparison of the inﬂuence of the ligand at
physiological and increased temperatures on lectin structure.
Because the ligand accommodation brought about a signif-
icant change in the radius of gyration, which we reported
above (Fig. 2), it is reasonable to assume that oligomer for-
mation could be different in the presence of ligand if one
raises the temperature to values denaturing the protein.
Indeed, the presence of ligand led to dissociation of octamers
of sheep galectin-1 to tetramers at 350 K and of tetramers of
bovine galectin-1 to dimers at a temperature slightly above
350 K (Surolia et al., 1997; Schwarz et al., 1998). Although
the oligomer status was reduced by ligand binding, the dimer
did not dissociate in both cases. Equally important, these
results illustrate that ligand binding signiﬁcantly affects the
properties of portions of galectin-1 involved in oligomer
FIGURE 7 Comparison of SANS behavior of VAA in 20 mM phosphate
buffer, pD 7.2, and in neat DMSO. Both spectra were recorded at 298 K. (A)
SANS spectra of VAA in the two solvents; (B) p(r) function of the scattering
data.
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formation which are not in the immediate vicinity of the
carbohydrate-binding site.
Taking our data and these results together, the ligand-
induced changes in solution could harbor biological
relevance. Because mammalian galectin-1 is known to be
engaged in protein-protein interactions besides carbohydrate
binding, e.g., targeting the oncogenic H-Ras (12 V) and the
pre-B cell receptor (Paz et al., 2001; Brewer, 2002; Elad-
Sfadia et al., 2002; Gauthier et al., 2002; Liu et al., 2002),
this potential for an intramolecular cross-talk with impli-
cation for cross-linking properties and signal triggering
(Brewer, 2002; Elad-Sfadia et al., 2002) deserves to be
tested. Literally, Gauthier et al. (2002) devised a model in
which galectin-1 can simultaneously contact protein and
carbohydrate ligands in the pre-B/stromal cell synapse.
Precedents for an intramolecular cross-talk between such
sites, i.e., the inﬂuence of lactose binding on protein-pro-
tein interaction, have been presented for the chimera-type
galectin-3 (bcl-2 and CBP70 as protein targets) and the
elastin/laminin receptor (Mecham et al., 1991; Se`ve et al.,
1994; Yang et al., 1996). Noting a conformational change in
the C-type lectin from Sarcophaga peregrina after binding
of galactose and the lactose-induced oligomer formation of
the Ca21-dependent sea cucumber lectin (Komano et al.,
1992; Fujisawa et al., 1997; Kuwahara et al., 2002), this
aspect and its functional implications on protein-protein
interactions deserve further interest. It is an open question
whether crystal packing of a protein will hinder this re-
activity toward ligand binding by diffusion into the crystal,
establishing this biophysical method as a main source of in-
formation in solution.
CONCLUSIONS
The quaternary structure of lectins has been recognized as an
essential factor in signal triggering, e.g., by virtue of cross-
linking of membrane ligands by prototype galectins (Villa-
lobo and Gabius, 1998; Brewer, 2002). For our pilot study on
lectins after a solvent exchange, we selected a representative
of this subgroup of a large family of endogenous lectins, i.e.,
galectin-1, as a role model. It folds into the general jellyroll-
like pattern, a versatile motif for generating different types of
oligomers (Ru¨diger and Gabius, 2001; Loris, 2002). When
working in water, we conﬁrmed the dimeric nature of human
galectin-1 as seen in the crystal. Differences of shape pro-
perties were within the limits of inherent error when
comparing crystal and solution structures. A notable result
is the impact of ligand binding on this lectin’s structure as
determined by our solution-scattering experiments. The com-
pact structure attained in the presence of the ligand together
with the peculiar behavior of galectin-1 in the cited studies
using differential scanning calorimetry revealed a remarkable
importance of binding-site occupation for the shape of the
lectin. Corroborating our data, an indication for this ligand-
dependent conformational change had been inferred by
monitoring tyrosine signals in the laser photo CIDNP tech-
nique, and molecular modeling also pointed to occurrence
of long-range conformational effects on structure by site-
speciﬁc mutations (Siebert et al., 1997).
The second aspect of this report concerns the behavior
of galectin-1 in an aprotic solvent. Similar to the current
development using enzymes in organic solvents for techno-
logical purposes, lectins retaining target speciﬁcities in an
organic medium also offer a variety of potential biotech-
nological applications. Unlike small lectins such as hevein or
carbohydrate-binding peptides with their inherently high
degree of ﬂexibility (Siebert et al., 2000, 2002), galectin-1’s
activity was not harmed when exposed to pure DMSO,
opening the route also to technological applications. Instead
of dissociation into subunits, galectin-1 dimers were quanti-
tatively converted to tetramers. Importantly, ab initio-derived
shape characteristics of galectin-1 in DMSO from the scat-
tering data conﬁrmed a cylindrical topology of human galec-
tin-1 in the aprotic solvent. Because the scattering technique
can be readily applied to other proteins in organic solvent, as
herein demonstrated for themistletoe lectin, if a concentration
of severalmgs/ml can be reached, this type of characterization
of conformational responses of lectins to ligand presence and
solvent change promises to provide further insights on intra-
and intermolecular interactions.
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